Artificial Intelligence (AI) offers exciting and unprecedented opportunities for life sciences and healthcare but also poses complex questions for the IP sector, as an LSPN Connect session discovered yesterday, July 21.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
3 June 2021 The implications of applying AI solutions must be carefully and fully considered before they are implemented, argues Mladen Vukmir of ECTA.
6 September 2021 Only a human being can be legally listed on a patent as an inventor, according to a Virginia federal judge who delivered the first US ruling in the worldwide debate on the patentability of AI inventions.
22 December 2021 The European Patent Office has ruled that only humans can invent, dismissing appeals looking to list an artificial intelligence as a named inventor on a patent.